{"disease":{"id":"pulmonary-tb","name":"pulmonary tb"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07118696","title":"Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Hamilton Health Sciences Corporation","has_results":false},{"nct_id":"NCT07135622","title":"Xpert MTB/RIF Ultra Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":778,"lead_sponsor_name":"Nestani Tukvadze","has_results":false},{"nct_id":"NCT04264221","title":"Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Farman Ullah Khan","has_results":false},{"nct_id":"NCT05824871","title":"A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Shanghai Jiatan Pharmatech Co., Ltd","has_results":false},{"nct_id":"NCT04645836","title":"Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'.","phase":"NA","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05040126","title":"Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Tuberculosis Research Centre, India","has_results":false},{"nct_id":"NCT05426720","title":"Risk Factors and Biomarkers for Post-tuberculosis Lung Damage","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT00933790","title":"Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Tuberculosis Research Centre, India","has_results":false},{"nct_id":"NCT03086486","title":"Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Global Alliance for TB Drug Development","has_results":true},{"nct_id":"NCT03678688","title":"A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05221502","title":"Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT05473195","title":"A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"TASK Applied Science","has_results":false},{"nct_id":"NCT06155747","title":"Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Jewish Health","has_results":false},{"nct_id":"NCT03821285","title":"Respiratory Function in Patients With Post-tuberculosis Lung Impairment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Università degli Studi dell'Insubria","has_results":false},{"nct_id":"NCT03561753","title":"Pilot Clinical Trial of PRS TB Regimen I - Phase II","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT07303699","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Obafemi Awolowo University Teaching Hospital","has_results":false},{"nct_id":"NCT07058233","title":"Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"RSUP Persahabatan","has_results":false},{"nct_id":"NCT03563599","title":"A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Qurient Co., Ltd.","has_results":false},{"nct_id":"NCT07069205","title":"Breathing Exercise and Tele-Nursing Support for Patients With Tuberculosis: A Single-Group Experimental Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Canan Güngör","has_results":false},{"nct_id":"NCT03722472","title":"Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Access to Advanced Health Institute (AAHI)","has_results":true}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}